U.S. Calls for Pause on Johnson & Johnson Vaccine After Blood Clotting Cases
U.S. Calls for Pause on Johnson & Johnson Vaccine After Blood Clotting Cases Noah Weiland, Sharon LaFraniere and Carl Zimmer © Go Nakamura for The New York Times People receiving the Johnson & Johnson vaccine at a high school in Houston last month. WASHINGTON — Federal health agencies on Tuesday called for an immediate pause in use of Johnson & Johnson’s single-dose coronavirus vaccine after six recipients in the United States developed a rare disorder involving blood clots within about two weeks of vaccination. All six recipients were women between the ages of 18 and 4...